{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-159994","form_type":"8-K","ticker":"CLYM","cik":"0001768446","company_name":"Climb Bio, Inc.","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.978500+00:00","generated_at":"2026-06-01T04:52:34.678626+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Eliem appoints Aoife Brennan as CEO and director, effective upon Tenet merger close","bullets":["Aoife Brennan appointed President and CEO, base salary $650K/yr, annual bonus target 55%.","Equity grant: incentive option for 550K shares and 275K RSUs, vesting over 4 years.","Stephen Thomas (Tenet CEO) appointed to board, expected to serve as consultant post-merger.","Andrew Levin to step down as principal executive officer but remain principal financial officer.","All appointments effective upon closing of Tenet acquisition; meeting on June 26, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-159994","json":"https://secwatch.observer/filing/0001193125-24-159994.json","markdown":"https://secwatch.observer/filing/0001193125-24-159994.md","text":"https://secwatch.observer/filing/0001193125-24-159994.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768446/000119312524159994/0001193125-24-159994-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768446/000119312524159994/d839370d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:52:34.678626+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0cacad4b5d","claim":"Aoife Brennan was appointed as President and Chief Executive Officer at Climb Bio, Inc..","evidence_excerpt":"appointed Aoife Brennan as President and Chief Executive Officer of Eliem, subject to and contingent and effective upon the closing of the Acquisition","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1768446/000119312524159994/0001193125-24-159994-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}